Dr. Thomas George Lundquist, M.D., M.M.M. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Marlboro Dr, Mcmurray, PA 15317 Phone: 724-941-5968 |
News Archive
Results published today in The New England Journal of Medicine from a Janssen Research & Development, LLC (Janssen)-sponsored Phase 2b trial showed up to 86 percent of patients with moderate to severe plaque psoriasis receiving guselkumab (CNTO 1959) achieved a Physician's Global Assessment (PGA) score of cleared psoriasis or minimal psoriasis at week 16, the study's primary endpoint.
EPIC Hearing Healthcare announced today that its Hearing Health Plan has been awarded the Health Network Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
Applied Automation Technologies, Inc. and DMG MORI USA Inc. will offer this innovative technology as a solution within the DMG MORI Qualified Products program.
The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology.
According to these stories from Politico and Politico Pro, some House Democrats are calling on the Department Of Health and Human Services to use the Medicare prescription drug program as a model for the health law's essential health benefits drug coverage requirement.
› Verified 5 days ago